Citations (24)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Stephan Brönimann, Benjamin Pradere, Pierre Karakiewicz, Mohammad Abufaraj, Alberto Briganti & Shahrokh F. Shariat. (2020) An overview of current and emerging diagnostic, staging and prognostic markers for prostate cancer. Expert Review of Molecular Diagnostics 20:8, pages 841-850.
Read now
Read now
Timothy N. Clinton, Aditya Bagrodia, Yair Lotan, Vitaly Margulis, Ganesh V. Raj & Solomon L. Woldu. (2017) Tissue-based biomarkers in prostate cancer. Expert Review of Precision Medicine and Drug Development 2:5, pages 249-260.
Read now
Read now
Articles from other publishers (22)
Simon K.B. Spohn, Cédric Draulans, Amar U. Kishan, Daniel Spratt, Ashley Ross, Tobias Maurer, Derya Tilki, Alejandro Berlin, Pierre Blanchard, Sean Collins, Peter Bronsert, Ronald Chen, Alan Dal Pra, Gert de Meerleer, Thomas Eade, Karin Haustermans, Tobias Hölscher, Stefan Höcht, Pirus Ghadjar, Elai Davicioni, Matthias Heck, Linda G.W. Kerkmeijer, Simon Kirste, Nikolaos Tselis, Phuoc T. Tran, Michael Pinkawa, Pascal Pommier, Constantinos Deltas, Nina-Sophie Schmidt-Hegemann, Thomas Wiegel, Thomas Zilli, Alison C. Tree, Xuefeng Qiu, Vedang Murthy, Jonathan I. Epstein, Christian Graztke, Xin Gao, Anca L. Grosu, Sophia C. Kamran & Constantinos Zamboglou. (2023) Genomic Classifiers in Personalized Prostate Cancer Radiation Therapy Approaches: A Systematic Review and Future Perspectives Based on International Consensus. International Journal of Radiation Oncology*Biology*Physics 116:3, pages 503-520.
Crossref
Crossref
Akshay Sood, Amar U. Kishan, Christopher P. Evans, Felix Y. Feng, Todd M. Morgan, Declan G. Murphy, Anwar R. Padhani, Peter Pinto, Henk G. Van der Poel, Derya Tilki, Alberto Briganti & Firas Abdollah. (2023) The Impact of Positron Emission Tomography Imaging and Tumor Molecular Profiling on Risk Stratification, Treatment Choice, and Oncological Outcomes of Patients with Primary or Relapsed Prostate Cancer: An International Collaborative Review of the Existing Literature. European Urology Oncology.
Crossref
Crossref
Gillian Parker, Sarah Hunter, Samer Ghazi, Robin Z. Hayeems, Francois Rousseau & Fiona A. Miller. (2023) Decision impact studies, evidence of clinical utility for genomic assays in cancer: A scoping review. PLOS ONE 18:3, pages e0280582.
Crossref
Crossref
Helen Pantazopoulos, Mame-Kany Diop, Andrée-Anne Grosset, Frédérique Rouleau-Gagné, Afnan Al-Saleh, Teodora Boblea & Dominique Trudel. (2022) Intraductal Carcinoma of the Prostate as a Cause of Prostate Cancer Metastasis: A Molecular Portrait. Cancers 14:3, pages 820.
Crossref
Crossref
Mark W. Farha & Simpa S. Salami. (2022) Biomarkers for prostate cancer detection and risk stratification. Therapeutic Advances in Urology 14, pages 175628722211039.
Crossref
Crossref
Manuel M Garrido, Rui M Bernardino, José C Marta, Stefan Holdenrieder & João T Guimarães. (2021) Tumour markers in prostate cancer: The post-prostate-specific antigen era. Annals of Clinical Biochemistry: International Journal of Laboratory Medicine 59:1, pages 46-58.
Crossref
Crossref
James Meehan, Mark Gray, Carlos Martínez-Pérez, Charlene Kay, Duncan McLaren & Arran K. Turnbull. (2021) Tissue- and Liquid-Based Biomarkers in Prostate Cancer Precision Medicine. Journal of Personalized Medicine 11:7, pages 664.
Crossref
Crossref
Spyridon P. Basourakos, Michael Tzeng, Patrick J. Lewicki, Krishnan Patel, Bashir Al Hussein Al Awamlh, Siv Venkat, Jonathan E. Shoag, Michael A. Gorin, Christopher E. Barbieri & Jim C. Hu. (2021) Tissue-Based Biomarkers for the Risk Stratification of Men With Clinically Localized Prostate Cancer. Frontiers in Oncology 11.
Crossref
Crossref
Neil K. Jairath, Alan Dal Pra, Randy VinceJr.Jr., Robert T. Dess, William C. Jackson, Jeffrey J. Tosoian, Sean M. McBride, Shuang G. Zhao, Alejandro Berlin, Brandon A. Mahal, Amar U. Kishan, Robert B. Den, Stephen J. Freedland, Simpa S. Salami, Samuel D. Kaffenberger, Alan Pollack, Phuoc Tran, Rohit Mehra, Todd M. Morgan, Adam B. Weiner, Osama Mohamad, Peter R. Carroll, Matthew R. Cooperberg, R. Jeffrey Karnes, Paul L. Nguyen, Jeff M. Michalski, Jonathan D. Tward, Felix Y. Feng, Edward M. Schaeffer & Daniel E. Spratt. (2021) A Systematic Review of the Evidence for the Decipher Genomic Classifier in Prostate Cancer. European Urology 79:3, pages 374-383.
Crossref
Crossref
R.T. Dess & D.E. Spratt. (2020) Why the UK Should Consider Gene Expression Testing in Prostate Cancer. Clinical Oncology 32:3, pages 149-155.
Crossref
Crossref
Rachel M. Glicksman & Alejandro Berlin. (2020) Genomic Strategies to Personalize Use of Androgen Deprivation Therapy With Radiotherapy. The Cancer Journal 26:1, pages 13-20.
Crossref
Crossref
William C. Jackson, Daniel E. Spratt & Todd M. Morgan. 2018. Prostate Cancer. Prostate Cancer
81
99
.
Chad A. Reichard & Eric A. Klein. 2018. Active Surveillance for Localized Prostate Cancer. Active Surveillance for Localized Prostate Cancer
121
133
.
Kathryn L. Pellegrini, Martin G. Sanda, Dattatraya Patil, Qi Long, María Santiago-Jiménez, Mandeep Takhar, Nicholas Erho, Kasra Yousefi, Elai Davicioni, Eric A. Klein, Robert B. Jenkins, R. Jeffrey Karnes & Carlos S. Moreno. (2017) Evaluation of a 24-gene signature for prognosis of metastatic events and prostate cancer-specific mortality. BJU International 119:6, pages 961-967.
Crossref
Crossref
Jennifer M. Lobo, Daniel M. Trifiletti, Vanessa N. Sturz, Adam P. Dicker, Christine Buerki, Elai Davicioni, Matthew R. Cooperberg, R. Jeffrey Karnes, Robert B. Jenkins, Robert B. Den & Timothy N. Showalter. (2017) Cost-effectiveness of the Decipher Genomic Classifier to Guide Individualized Decisions for Early Radiation Therapy After Prostatectomy for Prostate Cancer. Clinical Genitourinary Cancer 15:3, pages e299-e309.
Crossref
Crossref
Eric C. Ko, Anthony L. Michaud & Richard K. Valicenti. (2017) Postoperative Radiation After Radical Prostatectomy. Seminars in Radiation Oncology 27:1, pages 50-66.
Crossref
Crossref
J. Scott Ferguson, Ryan Van Wert, Yoonha Choi, Michael J. Rosenbluth, Kate Porta Smith, Jing Huang & Avrum Spira. (2016) Impact of a bronchial genomic classifier on clinical decision making in patients undergoing diagnostic evaluation for lung cancer. BMC Pulmonary Medicine 16:1.
Crossref
Crossref
R B Den, M Santiago-Jimenez, J Alter, M Schliekelman, J R Wagner, J F Renzulli II, D I Lee, C G Brito, K Monahan, B Gburek, N Kella, G Vallabhan, F Abdollah, E J Trabulsi, C D Lallas, L G Gomella, T L Woodlief, Z Haddad, L L C Lam, S Deheshi, Q Wang, V Choeurng, M du Plessis, J Jordan, B Parks, H Shin, C Buerki, K Yousefi, E Davicioni, V R Patel & N L Shah. (2016) Decipher correlation patterns post prostatectomy: initial experience from 2 342 prospective patients. Prostate Cancer and Prostatic Diseases 19:4, pages 374-379.
Crossref
Crossref
Liyan Zhuang & Matthew T. Johnson. (2016) How Precisely Can Prostate Cancer Be Managed?. International Neurourology Journal 20:Suppl 2, pages S120-130.
Crossref
Crossref
Pierre-Olivier GaudreauJohn StaggDenis SoulièresFred Saad. (2016) The Present and Future of Biomarkers in Prostate Cancer: Proteomics, Genomics, and Immunology Advancements. Biomarkers in Cancer 8s2, pages BIC.S31802.
Crossref
Crossref
Eric A. Klein, Kasra Yousefi, Zaid Haddad, Voleak Choeurng, Christine Buerki, Andrew J. Stephenson, Jianbo Li, Michael W. Kattan, Cristina Magi-Galluzzi & Elai Davicioni. (2015) A Genomic Classifier Improves Prediction of Metastatic Disease Within 5 Years After Surgery in Node-negative High-risk Prostate Cancer Patients Managed by Radical Prostatectomy Without Adjuvant Therapy. European Urology 67:4, pages 778-786.
Crossref
Crossref
Hao G. Nguyen, Christopher J. Welty & Matthew R. Cooperberg. (2015) Diagnostic associations of gene expression signatures in prostate cancer tissue. Current Opinion in Urology 25:1, pages 65-70.
Crossref
Crossref